Related Experiment Video
Updated: Aug 17, 2026

Laboratory Scale Production and Purification of a Therapeutic Antibody
Published on: January 24, 2017
An Introduction to "Recent Trends in the Biotechnology Industry: Development and Manufacturing of Recombinant
Michael Pohlscheidt1, Robert Kiss2, Uwe Gottschalk2
1Biogen International GmbH, International Manufacturing, Zug, Switzerland. michael.pohlscheidt@biogen.com.
Abstract:
The production of the first therapeutic proteins in the early 1980s heralded the launch of the biopharmaceuticals industry. The number of approved products has grown year on year over the past three decades to now represent a significant share of the entire pharmaceuticals market. More than 200 therapeutic proteins have been approved, approximately a quarter of which are represented by monoclonal antibodies and their derivatives. In 2016, the list of the top 15 best-selling drugs included more than eight biologics and in 2020 the trend will continue, with more than 50% of the top 20 best-selling drugs predicted to be biologics. From 1986 to 2014 several first-in-class, advance-in-class, and breakthrough designated therapeutic options were approved, with advanced therapies such as immuno-oncology and cell-based therapies being approved for several indications.
More Related Videos
Related Concept Videos
Recombinant DNA
Recombinant DNA
The Central Dogma
RNA is the Missing Link Between DNA and Proteins
In the early 1900s, scientists discovered that DNA stores all the information needed for cellular functions and that proteins perform most of these functions. However, the mechanisms of converting genetic information into functional proteins remained unknown for many years. Initially, it was believed that a single gene is...
Hybridoma Technology
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...
Upstream Processing
Production of Pharmaceuticals

